Stroke Prevention 
The MD Magazine Stroke Prevention condition center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.


Trans Fats Restrictions May Be Working, Yale Study Finds
People who restrict trans fats are hospitalized less for MIs and strokes.
Using the database from the 40-country, double-blind phase 3 ARISTOTLE study, which has been around for over 5 years, a sub-analysis was conducted by Renato Lopes, MD, PhD, professor of Medicine at Duke University in Durham, North Carolina and colleagues.
FDA gives priority review designation for exertional heat stroke drug.
Compared with warfarin, are direct oral anticoagulants (DOACs), including apixaban, dabigatran, and rivaroxaban, better at reducing stroke and major bleeding risks in patients with non-valvular atrial fibrillation? Alpesh Amin, MD, professor of medicine at the University of California, Irvine breaks it down at ACC 2017 in Washington, District of Columbia.
In patients with AFib, digoxin should not be a first-line drug.
Heart damage after non-cardiac surgery is usually missed. A test finds it.
In the first head to head trial, rivaroxaban was more effective than aspirin.
A synthetic version of "good" cholesterol failed to clear blocked arteries.
Bleeding complications with rivaroxaban no worse than with aspirin.

Most Popular


$vacMongoViewPlus$ $vAR$